Prophylaxis and the mechanism for the initiation of organophosphorous compound-induced delayed neurotoxicity
- 1 May 1989
- journal article
- Published by Springer Nature in Archives of Toxicology
- Vol. 63 (3) , 165-172
- https://doi.org/10.1007/bf00316365
Abstract
Recent work concerned with the mechanism underlying the development of organophosphorous compound-induced delayed neurotoxicity (OPIDN) is reviewed. Topics covered include the prophylaxis of OPIDN by phenylmethylsulfonyl fluoride and other agents, neurotoxic esterase (NTE) as measured using either labelled diisopropyl phosphorofluoridate or an esterase assay, and the relationship between NTE and the development of OPIDN. There is considerable evidence that NTE has the biochemical properties which should be expected for the initiation site for OPIDN. However, the in vitro assays as currently performed may not entirely reflect the behavior of organophosphorous compounds in vivo, or the assays may not be sensitive enough to identify the actual target. It is argued that prophylaxis is a distinguishing characteristic of OPIDN which is not necessarily related to NTE inhibition, although it does provide evidence that NTE is involved. It is concluded that the NTE hypothesis could be furthered by additional studies with peripheral nerve, more sensitive methods for the detection of potential binding sites, and the establishment of a physiological role for NTE which relates it to the neuropathy.Keywords
This publication has 54 references indexed in Scilit:
- Kinetics of substrate hydrolysis and inhibition by mipafox of paraoxon-preinhibited hen brain esterase activityBiochemical Journal, 1986
- Target size of neurotoxic esterase and acetylcholinesterase as determined by radiation inactivationBiochemical Journal, 1985
- Characterization of [3H]di-isopropyl phosphorofluoridate-binding proteins in hen brain. Rates of phosphorylation and sensitivity to neurotoxic and non-neurotoxic organophosphorus compoundsBiochemical Journal, 1985
- Intramolecular group transfer is a characteristic of neurotoxic esterase and is independent of the tissue source of the enzyme. A comparison of the aging behaviour of di-isopropyl phosphorofluoridate-labelled proteins in brain, spinal cord, liver, kidney and spleen from hen and in human placentaBiochemical Journal, 1983
- Gel-electrophoretic identification of hen brain neurotoxic esterase, labelled with tritiated di-isopropyl phosphorofluoridateBiochemical Journal, 1981
- Organophosphorus Ester-Induced Delayed NeurotoxicityAnnual Review of Pharmacology and Toxicology, 1981
- Organophosphorus and other inhibitors of brain ‘neurotoxic esterase’ and the development of delayed neurotoxicity in hensBiochemical Journal, 1970
- The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esteraseBiochemical Journal, 1969
- A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compoundsBiochemical Journal, 1969
- The Pharmacological Action of Certain Phenol Esters, with Special Reference to the Etiology of So-Called Ginger Paralysis (Second Report)Public Health Reports (1896-1970), 1930